China Medical System Holdings Limited (the 'Company”, together with its subsidiaries, the 'Group” or 'CMS”) is pleased to announce that on 8 January 2025, the Group through a wholly-owned subsidiary ...
ARS Pharma retains all U.S. rights for neffy and has existing licensing partnerships in China, Japan, Australia and New Zealand with Pediatrix Therapeutics, Alfresa Pharma, and CSL Seqirus, ...